ATE360456T1 - Verwendung von kohlenhydraten zur verbesserung der haut barrierefunktion - Google Patents

Verwendung von kohlenhydraten zur verbesserung der haut barrierefunktion

Info

Publication number
ATE360456T1
ATE360456T1 AT01993445T AT01993445T ATE360456T1 AT E360456 T1 ATE360456 T1 AT E360456T1 AT 01993445 T AT01993445 T AT 01993445T AT 01993445 T AT01993445 T AT 01993445T AT E360456 T1 ATE360456 T1 AT E360456T1
Authority
AT
Austria
Prior art keywords
barrier function
carbohydrates
skin barrier
improve skin
carbamate
Prior art date
Application number
AT01993445T
Other languages
English (en)
Inventor
Bruno Mehul
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE360456T1 publication Critical patent/ATE360456T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01993445T 2000-11-13 2001-11-13 Verwendung von kohlenhydraten zur verbesserung der haut barrierefunktion ATE360456T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014557A FR2816505B1 (fr) 2000-11-13 2000-11-13 Utilisation de carbohydrate pour ameliorer la fonction barriere de la peau

Publications (1)

Publication Number Publication Date
ATE360456T1 true ATE360456T1 (de) 2007-05-15

Family

ID=8856368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01993445T ATE360456T1 (de) 2000-11-13 2001-11-13 Verwendung von kohlenhydraten zur verbesserung der haut barrierefunktion

Country Status (8)

Country Link
US (2) US20040062739A1 (de)
EP (2) EP1333803B1 (de)
JP (2) JP2004517061A (de)
AT (1) ATE360456T1 (de)
DE (1) DE60128127T2 (de)
ES (1) ES2284724T3 (de)
FR (1) FR2816505B1 (de)
WO (1) WO2002038110A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816504B1 (fr) * 2000-11-13 2003-04-18 Oreal Compositions comprenant au moins une glycosidase, lesdites compositions ne comprenant pas de protease
ES2526540T3 (es) 2009-12-07 2015-01-13 Chanel Parfums Beauté Método para seleccionar agentes activos que estimulan la expresión de CERT para mejorar las funciones de barrera de la piel
FR2991582B1 (fr) * 2012-06-11 2014-06-13 Isp Investments Inc Extrait de fibres de coton et composition cosmetique et leur utilisation pour proteger, nourrir et hydrater la peau
FR3078257B1 (fr) 2018-02-23 2020-12-25 Oreal Utilisation cosmetique d'un hydrolat de sarriette citronnee pour ameliorer la fonction barriere de la peau
FR3100981A1 (fr) 2019-06-19 2021-03-26 L'oreal Dérivés xylosides de resvératrol pour leur utilisation en cosmétique
FR3111817B1 (fr) 2020-06-30 2023-05-12 Oreal Extrait d’Hibiscus sabdariffa et son utilisation pour améliorer la fonction barrière, et favoriser l’hydratation et la desquamation de la peau
FR3111818B1 (fr) 2020-06-30 2023-04-14 Oreal Hydrolat de Thymus vulgaris chemotype α-terpinéol ou fragrantissimus et son utilisation pour améliorer la fonction barrière de la peau

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61194007A (ja) * 1985-02-22 1986-08-28 Shiseido Co Ltd 皮膚外用剤
JPS63222698A (ja) * 1987-03-11 1988-09-16 Asahi Denka Kogyo Kk マルト−ス類脂肪酸エステルの製造法
FR2689131B1 (fr) * 1992-03-30 1994-05-20 Oreal Procede de preparation de monoesters majoritairement en position 6' du d-maltose et leur utilisation dans les domaines cosmetique, bucco-dentaire, pharmaceutique et alimentaire.
US5507970A (en) * 1992-05-29 1996-04-16 Lion Corporation Detergent composition
FR2696467B1 (fr) * 1992-10-05 1994-11-04 Oreal Procédé de préparation de monoesters d'acides gras du D-fructose et leur utilisation dans les domaines cosmétique, bucco-dentaire, pharmaceutique et alimentaire.
DK144292D0 (da) * 1992-12-01 1992-12-01 Novo Nordisk As Forbedret fremgangsmaade
DE4424530A1 (de) * 1994-07-12 1996-01-18 Henkel Kgaa Pseudoceramide
FR2725131B1 (fr) * 1994-09-29 1996-10-31 Oreal Utilisation de n-(hydroxyalkyl)carbamates d'alkyle dans une composition cosmetique
FR2739556B1 (fr) * 1995-10-04 1998-01-09 Oreal Utilisation de carbohydrates pour favoriser la desquamation de la peau
US5925348A (en) * 1996-02-23 1999-07-20 Medical Doctor's Research Institute, Inc. Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
FR2750334B1 (fr) * 1996-07-01 1998-09-04 Oreal Utilisation de derives amino-alcools a fonction uree dans et pour la preparation de compositions cosmetiques ou dermatologiques
US6649175B1 (en) * 1998-05-04 2003-11-18 Schering-Plough Healthcare Products, Inc. Skin barrier composition
FR2816504B1 (fr) * 2000-11-13 2003-04-18 Oreal Compositions comprenant au moins une glycosidase, lesdites compositions ne comprenant pas de protease

Also Published As

Publication number Publication date
WO2002038110A3 (fr) 2002-08-08
DE60128127D1 (de) 2007-06-06
WO2002038110A2 (fr) 2002-05-16
DE60128127T2 (de) 2008-01-24
JP2004517061A (ja) 2004-06-10
US20060165632A1 (en) 2006-07-27
JP2009137957A (ja) 2009-06-25
EP1333803A2 (de) 2003-08-13
FR2816505A1 (fr) 2002-05-17
EP1803437A1 (de) 2007-07-04
FR2816505B1 (fr) 2003-05-02
US20040062739A1 (en) 2004-04-01
ES2284724T3 (es) 2007-11-16
EP1333803B1 (de) 2007-04-25

Similar Documents

Publication Publication Date Title
DE60143984D1 (de) Neue phenylalanin-derivate
BR0116539A (pt) Derivados de piridona tendo uma atividade de ligação para o receptor 2 do tipo canabinóide
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
CY1109313T1 (el) Ενωσις φωσφονοκεφεμιου
DE122006000004I2 (de) Fungizide Tetrahydrofurane
BR0211502A (pt) Derivados de ácido acético de indano e seu uso como agentes farmacêuticos, intermediários, e método de preparação
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
CY1110242T1 (el) Αλας παραγωγου 7-ισοϊνδολινοκινολονοκαρβοξυλικου οξεος, μονενυδρη μορφη αυτου και συνθεση περιεχουσα τα ιδια ως δραστικο συστατικο
ATE360456T1 (de) Verwendung von kohlenhydraten zur verbesserung der haut barrierefunktion
CY1105598T1 (el) Μεθοδοι για την παρασκευη αντιβακτηριακων παραγοντων τυπου carbapenem
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
DE60104825D1 (de) Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
ES2186615T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
DK1327146T3 (da) Forbindelse med et forgrenet linkermolekyle
ATE367374T1 (de) Sulphonsäurederivate von hydroxamsäuren und deren verwendung in medizinischen produkten
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
PT1102765E (pt) Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas
EA200400069A1 (ru) Способ получения производных циклогексанола
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
DK0668279T3 (da) 6-azaindol thromboxansytaseinhibitor
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
BR9806875A (pt) Processo para a preparação de um composto.
ATE393160T1 (de) Derivative von 9,10-dihydro-9-oxa-10- phosphaphenanthren-10-oxid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties